Racial Disparities in Itch
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Shawn Kwatra, associate professor of dermatology at Johns Hopkins University School of Medicine. Dr. Kwatra shares what dermatology clinicians need to know about racial disparities in itch. Find out how disease prevalence and presentation play a role in these disparities. Watch as Dr. Kw …
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Shawn Kwatra, associate professor of dermatology at Johns Hopkins University School of Medicine. Dr. Kwatra shares what dermatology clinicians need to know about racial disparities in itch. Find out how disease prevalence and presentation play a role in these disparities. Watch as Dr. Kw … 
As dermatologists, pruritus (or itch) is one of the most frequent symptoms that we encounter. The broad spectrum of itch severity in patients with various dermatologic conditions suggests a need for a host of “tools” or medications that dermatologists should have in their toolbox. In this publication, we continue our Therapeutic Cheat Sheet series by highlighting the uses of Doxepin in dermato … 
During the recent DERM2O22 NP/PA CME conference held July 28-31, 2022, Drs. David Cohen, Brad Glick, and Adam Friedman led a case-based panel discussion on atopic dermatitis (AD) treatment initiation and monitoring. This article provides a summary of their discussion and recommendations.
CASE 1
51-year-old male with a 20-year history of AD. The patient was first seen in September 2015 with BSA … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Adam Friedman (Professor and Chair of Dermatology, Residency Program Director, Director of Translational Research, and Director of the Supportive Oncodermatology Program in the GW Department of Dermatology) about which options work best for treating Urticaria. Watch as he reveals various st … 
Data-Driven Dermatology Improves Patient Outcomes
The use of real-world data and real-world evidence to inform health care decisions is increasing. While randomized controlled trials (RCTs) are still the gold standard for evidence-based medicine, the strict inclusion/exclusion criteria and tightly controlled conditions limit their generalizability to real-world clinical practice. Real worl … 